Wednesday, February 21, 2024 at 12:00 PM
This grand round has already taken place.
February 21st, 2024 1.00 AMA PRA Category 1 Credit Hours
Description
Optical Genome Mapping is a new technology that offers significant advantages over routine cytogenetic techniques for patients with AML. These include an increased diagnostic rate as well as improved identification of patients eligible for clinical trials.
Dates and Times
Start: 2/21/2024 12:00 PM
End: 2/21/2024 1:00 PM
Objectives
1) State the potential increased diagnostic yield that optical genome mapping provides for patients with acute myeloid leukemia compared to routine karyotyping
2) Describe the basic optical genome mapping process
3) State how optical genome mapping differs to NGS
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Amy Loughlin
Department: Pathology
Phone: (631) 444-3000
Email: Amy.loughlin@stonybrookmedicine.edu